-transparent.png){kind=logo}
The absorption of simultaneously administered equimolar doses of 14C vitamin D3 and 3H 25 hydroxyvitamin D3 (25-OH-D3) has been studied in controls and patients with a variety of gastrointestinal disorders. As assessed from peak radioactivity in the serum and from faecal excretion of radioactivity, malabsorption of both vitamin D3 and 25-OH-D3 occurred in patients with steatorrhoea. Malabsorption of vitamin D3 was greater than 25-OH-D3. The magnitude of malabsorption of these compounds was related to the severity of the steatorrhoea but was moderate enough to suggest that replacement therapy in patients with intestinal malabsorption should be accomplished with relatively small doses of vitamin D. The more potent vitamin D metabolites are probably unnecessary in this situation.
M Davies, and
E B Mawer, and
E L Krawitt
April 1979,
The American journal of physiology,
M Davies, and
E B Mawer, and
E L Krawitt
November 1983,
The American journal of physiology,
M Davies, and
E B Mawer, and
E L Krawitt
January 1986,
Methods in enzymology,
M Davies, and
E B Mawer, and
E L Krawitt
May 1983,
Analytical biochemistry,
M Davies, and
E B Mawer, and
E L Krawitt
April 2018,
The Journal of nutrition,
M Davies, and
E B Mawer, and
E L Krawitt
January 2019,
Bioanalysis,
M Davies, and
E B Mawer, and
E L Krawitt
January 1976,
Biochimica et biophysica acta,
M Davies, and
E B Mawer, and
E L Krawitt
January 1988,
Journal of pediatric gastroenterology and nutrition,
M Davies, and
E B Mawer, and
E L Krawitt
June 1978,
The Journal of biological chemistry,
M Davies, and
E B Mawer, and
E L Krawitt
September 1983,
Chemical & pharmaceutical bulletin,
